Kazia Therapeutics (KZIA) Gains from Investment Securities (2017 - 2020)
Kazia Therapeutics (KZIA) posted Gains from Investment Securities of $80071.7 for Q4 2020, down 83.98% on a QoQ basis from $499763.6 in Q4 2017.
Kazia Therapeutics (KZIA) has 2 years of Gains from Investment Securities data on file, last reported at $80071.7 in Q4 2020.
- In Q4 2020, Gains from Investment Securities changed N/A year-over-year to $80071.7; the TTM figure through Dec 2017 stood at $499763.6 (changed N/A YoY), while the FY2016 annual figure was -$414685.3, changed N/A from the prior year.
- Gains from Investment Securities fell to $80071.7 in Q4 2020, from $499763.6 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $499763.6 in Q4 2017 and bottomed at $80071.7 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 80,071.71 |
| Dec 31, 2020 | 80,071.71 |
| Dec 31, 2017 | 499,763.55 |
| Dec 31, 2017 | 499,763.55 |